Creatine and Cognition

Why this comes up at all

Creatine is sold in the sports aisle, which is why the cognitive question surprises people.

The reason it is a serious question is bioenergetic. Creatine's job in muscle is to regenerate ATP rapidly during short bursts of high demand, by donating a phosphate group. That is why it helps with heavy sets and sprints.

Your brain runs on the same currency. It is roughly two percent of your body weight and consumes something like twenty percent of your energy, and it has the same phosphocreatine system for buffering rapid demand.

So the hypothesis is straightforward rather than exotic: if creatine augments brain creatine stores, and brain performance is partly energy limited, then supplementation might affect cognition.

That hypothesis has now been tested enough times to meta-analyse, which is a better position than most supplement questions are in.

What the human evidence actually shows

Two meta-analyses are worth having, and the useful thing is that they agree on the shape while differing in emphasis.

A 2024 systematic review and meta-analysis in Frontiers in Nutrition, following PRISMA and pre-registered on PROSPERO, included 16 randomized controlled trials with 492 participants aged 20.8 to 76.4 years. Creatine monohydrate was the form used in every included study.

It found significant positive effects on memory, on attention time, and on processing speed. And it found no significant improvement in overall cognitive function or in executive function.

That specificity matters, and it is the part most write-ups skip. Creatine did not make people generally smarter in these trials. It moved particular measures.

The subgroup findings are equally worth having: benefit was greater in individuals with diseases, in those aged 18 to 60, and in females.

A 2023 meta-analysis in Nutrition Reviews looked specifically at memory in healthy people, including 10 trials with 8 in the meta-analysis. Overall, creatine improved memory measures against placebo with a standardised mean difference of 0.29.

Then the striking subgroup split. In older adults aged 66 to 76 the effect was substantial at SMD 0.88. In younger participants aged 11 to 31, it was essentially nothing, at SMD 0.03.

Dose from roughly 2.2 to 20 grams daily, duration from 5 days to 24 weeks, sex and geographical origin did not influence the findings.

So the honest summary: real, modest, domain-specific, and considerably larger in older adults than in young healthy ones.

What this means in practice

The first practical consequence is about expectations. If you are twenty-five, healthy and sleeping well, the memory evidence in your age group is close to flat. Creatine may still be worth taking for what it was originally sold for, and the cognitive effect is not the reason.

If you are older, the picture is different and the effect size in that subgroup was genuinely meaningful.

The second consequence is about form. Every trial in the 2024 review used creatine monohydrate. That is the researched form, it is the cheapest form, and the more expensive alternatives do not have this evidence base behind them.

The third is about what creatine is competing with. A 2021 randomized crossover study found four nights of four-hour sleep produced measurable insulin resistance in healthy young men, and short sleep degrades attention and memory far more reliably than any supplement improves them.

So if cognition is the goal and you are sleeping six hours, the sleep is the larger lever by a wide margin, and it is free. That is not a reason to skip creatine. It is a reason not to expect a supplement to outrun a deficit it never caused.

The honest hedge

I am not a doctor and I am not diagnosing anyone.

The effect sizes here are modest and I want to state them as such rather than round them up. An SMD of 0.29 for memory in healthy people is a real signal in a meta-analysis, and it is not a transformation you will necessarily notice day to day.

The 2024 review also reported heterogeneity across studies, meaning the trials did not all point the same way with the same strength, which is normal in this literature and is a reason for measured claims rather than confident ones.

On safety, creatine monohydrate is among the more studied supplements there is, with a long record in athletic populations. Worth mentioning to your provider if you have kidney disease, since that is the population where the question genuinely warrants a conversation rather than an assumption.

And a point that applies to this whole page type: none of this tells you what creatine would do for you specifically. Meta-analyses describe averages across groups, and you are not an average.

What to do with this

Buy the researched form. Creatine monohydrate is what every trial in the 2024 review used, and it is the cheapest option rather than the most expensive.

Set expectations by age. The memory effect in the 2023 meta-analysis was substantial in the 66 to 76 group and essentially absent in the 11 to 31 group. That is the single most useful thing to know before buying.

Fix the sleep first if it is broken. Short sleep degrades exactly the domains creatine modestly improves, and it is free to address.

Give it weeks rather than days. Trial durations ran from 5 days to 24 weeks without dose or duration influencing the findings, so there is no need to load aggressively, and no reason to judge it after a weekend.

Mention it to your provider if you have kidney disease. That is the one population where this is a real conversation.

Do not expect it to fix executive function. The 2024 review specifically found no significant improvement there, and knowing what a supplement does not do is as useful as knowing what it does.

Where the paid report goes further

This page covers what the published evidence says in general. It cannot tell you what it means for you, because it does not know your medications, your labs, your history, or your dose.

A paid research report does that work. Jess builds it around your actual situation, walks the citations, and writes what the evidence supports for someone in your position. The brief is the shorter version. The deep dive is the one where every citation is read and the reasoning is laid out end to end, and Jess reviews every deep dive personally before it goes out.

Neither is medical advice, and neither replaces your prescriber. What they replace is the evening you would otherwise spend trying to work out which of forty search results is telling you the truth.